...
首页> 外文期刊>Strahlentherapie und Onkologie >Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold
【24h】

Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold

机译:在型乳腺癌辐照过程中不同淋巴结水平的剂量变异性:深吸气息呼吸的影响

获取原文
获取原文并翻译 | 示例

摘要

PurposeAim of the present analysis was to evaluate the movement and dose variability of the different lymph node levels of node-positive breast cancer patients during adjuvant radiotherapy(RT) with regional nodal irradiation (RNI) in deep-inspiration breath hold (DIBH).MethodsThirty-five consecutive node-positive breast cancer patients treated from October 2016 to February 2018 receiving postoperative RT of the breast or chest wall including RNI of the supra-/infraclavicular lymph node levels (corresponding to levelsIV, III, Rotter LN (interpectoral), and some parts of levelII) were analyzed. To evaluate the lymph node level movement, acenter of volume (COV) was obtained for each lymph node level for free-breathing (FB) and DIBH plans. Geometric shifts and dose differences between FB and DIBH were analyzed.ResultsAsignificant movement of the COV in anterior(y) and cranial(z) dimensions was observed for lymph node levelsI-II and Rotter lymph nodes (p0.001) due to DIBH. Only minor changes in the lateral dimension (xaxis) were observed, without reaching significance for levelsIII, IV, and internal mammary. There was asignificant difference in the mean dose of levelI (DIBH vs. FB: 38.2Gy/41.3Gy, p0.001) and levelII (DIBH vs. FB: 45.9Gy/47.2Gy, p0.001), while there was no significant difference in levelIII (p=0.298), levelIV (p=0.476), or internal mammary nodes (p=0.471).ConclusionAsignificant movement of the axillary lymph node levels was observed during DIBH in anterior and cranial directions for node-positive breast cancer patients in comparison to FB. The movement leads to asignificant dose reduction in levelI and levelII.
机译:目前分析的预防率是在佐剂放射疗法(RT)期间,在深色呼吸呼吸暂停(Dibh)中,评估节点阳性乳腺癌患者的不同淋巴结水平的运动和剂量变异性。方法。方法 - 从2016年10月到2018年10月治疗的连续节点阳性乳腺癌患者接受乳房或胸壁的术后RT,包括Supra-/ InfraAviCicular淋巴结水平的RNI(对应于Systociv,III,转子LN(内侧)和分析了levelII的某些部分。为了评估淋巴结水平运动,为每条淋巴结水平获得淋巴结水平运动,为自由呼吸(FB)和DIBH计划获得淋巴结水平。分析了FB和DIBH之间的几何偏移和剂量差异。由于DIBH,观察到前部(Y)和颅骨(Z)尺寸的COV中的COV的显微成分,由于DIBH,转子淋巴结(P <0.001)。观察到横向尺寸(Xaxis)的微小变化,而不达到水平,IV和内部乳腺的意义。平均剂量的含量差异很大(DibH与FB:38.2Gy / 41.3.Gy,P <0.001)和LevelII(DibH与FB:45.9Gy / 47.2gy,P <0.001),同时没有显着Ⅰ级(p = 0.298),体育率(p = 0.476)或内部乳腺节点(p = 0.471)。在节点阳性乳腺癌患者的前和颅骨方向中的DIBH期间观察到腋窝淋巴结水平的组分。与FB相比。运动导致施足和levelii的减少剂量减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号